Paid Clinical Trials Reno

Discover 50 paid clinical trials in Reno, Nevada. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 50

Alisertib & Endocrine TherapyA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Recruiting

PHASE2

Sponsor:

Puma Biotechnology, Inc.

Location:

Reno NV, San Francisco CA, Los Angeles CA, Irvine CAshow 18 more

Code:

NCT06369285

Conditions

Hormone Receptor Positive HER-2 Negative Breast Cancer

Metastatic Breast Cancer

Recurrent Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Alisertib

Endocrine therapy

PF-07220060 with LetrozoleStudy of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

Recruiting

PHASE3

Sponsor:

Pfizer

Location:

Reno NV, Portland OR, Glendale AZ, Phoenix AZshow 23 more

Code:

NCT06760637

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-07220060

letrozole

abemaciclib

palbociclib

ribociclib

Biobank RegistryTEMPUS ARIES: A Biobank Registry Platform Study in Oncology

Recruiting

Sponsor:

Tempus AI

Location:

Reno NV, Las Vegas NV, Fargo ND, Springfield MOshow 20 more

Code:

NCT06207032

Conditions

Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Pembrolizumab & Sacituzumab TirxumotecanA Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Reno NV, San Francisco CA, Beverly Hills CA, Los Angeles CAshow 22 more

Code:

NCT06312137

Conditions

Non Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab tirumotecan

Pembrolizumab

Cisplatin

Pemetrexed

Gemcitabine

Interspinous FusionREFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

Recruiting

Sponsor:

Pacific Research Institute

Location:

Reno NV, Santa Rosa CA, Henderson NV, Slidell LAshow 5 more

Code:

NCT05504499

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Interspinous Fusion

RLY-2608 & FulvestrantFirst-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, As a Single Agent in Advanced Solid Tumor Patients and in Combination with Fulvestrant in Patients with Advanced Breast Cancer

Recruiting

PHASE1

Sponsor:

Relay Therapeutics, Inc.

Location:

Reno NV, Salt Lake City UT, San Diego CA, Tucson AZshow 16 more

Code:

NCT05216432

Conditions

PIK3CA Mutation

Solid Tumor, Adult

HER2-negative Breast Cancer

Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RLY-2608

Fulvestrant

Palbociclib 125mg

Ribociclib 400mg

Ribociclib 600mg

SCSMulticenter Outcome Registry of AnaLgesic Effect of SCS(MORALES) Registry Protocol

Recruiting

Sponsor:

Cardio Surgical Partners

Location:

Reno NV

Code:

NCT04548375

Conditions

SCS

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Accepted

Interventions

SCS

CPR GameOvercoming Barriers to Performing CPR Using a Novel, Interactive CPR Game System

Recruiting

Sponsor:

University of Nevada, Reno

Location:

Reno NV

Code:

NCT05908500

Conditions

Cardiac Arrest, Out-Of-Hospital

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Accepted

Interventions

CPR Training

E-cigarettesFeasibility and Acceptability of Switching to E-cigarettes Among Cigarette Smokers Engaged in SUD Treatment

Recruiting

PHASE1

Sponsor:

University of Nevada, Reno

Location:

Reno NV

Code:

NCT05918887

Conditions

Tobacco Dependence Caused by Cigarettes

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

NJOY ACE commercial e-cigarette

ZN-c3A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma

Recruiting

PHASE2

Sponsor:

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Location:

Reno NV, San Francisco CA, Eugene OR, Orange CAshow 32 more

Code:

NCT04814108

Conditions

Uterine Serous Carcinoma

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ZN-c3